MicroRNA-204 Potentiates the Sensitivity of Acute Myeloid Leukemia Cells to Arsenic Trioxide

Although arsenic trioxide (ATO) is a well-known antileukemic drug used for acute promyelocytic leukemia treatment, the development of ATO resistance is still a big challenge. We previously reported that microRNA-204 (miR-204) was involved in the regulation of acute myeloid leukemia (AML) cell apopto...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhiguo, Fang, Zehui, Lu, Runzhang, Zhao, Hongli, Gong, Tiejun, Liu, Dong, Hong, Luojia, Ma, Jun, Zhang, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848422/
https://www.ncbi.nlm.nih.gov/pubmed/30982490
http://dx.doi.org/10.3727/096504019X15528367532612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848422/
https://www.ncbi.nlm.nih.gov/pubmed/30982490
http://dx.doi.org/10.3727/096504019X15528367532612

Ejemplares similares